BioLife Solutions, Inc. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
BioLife Solutions, Inc. (BLFS) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$343.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2026-08-06
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2026-06-30 was -$91.00K, a 262.50% decline year-over-year.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2026-03-31 was -$252.00K.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-12-31 was $2.00K, a 92.86% decline year-over-year.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-09-30 was $59.00K.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2025 was $108.00K.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was -$18.00K.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was -$56.00K, a 212.00% decline from fiscal 2022.
- BioLife Solutions, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was $50.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$343.00K 10-Q · filed 2026-08-06 | -$341.00K derived: sum of 3 quarters · filed 2026-08-06 | -$282.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$252.00K 10-Q · filed 2026-05-07 | -$250.00K derived: sum of 2 quarters · filed 2026-05-07 | -$191.00K derived: sum of 3 quarters · filed 2026-05-07 | -$135.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.00K derived: sum of 2 quarters · filed 2026-02-26 | $117.00K derived: sum of 3 quarters · filed 2026-08-06 | $108.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $115.00K derived: sum of 2 quarters · filed 2026-08-06 | $106.00K 10-Q · filed 2025-11-06 | $134.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $47.00K 10-Q · filed 2026-08-06 | $75.00K derived: sum of 3 quarters · filed 2026-08-06 | $11.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$9.00K 10-Q · filed 2026-05-07 | $19.00K derived: sum of 2 quarters · filed 2026-05-07 | -$45.00K derived: sum of 3 quarters · filed 2026-05-07 | -$45.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$36.00K derived: sum of 2 quarters · filed 2026-02-26 | -$36.00K derived: sum of 3 quarters · filed 2026-02-26 | -$18.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$64.00K derived: sum of 2 quarters · filed 2025-11-06 | -$46.00K 10-Q · filed 2025-11-06 | -$58.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $18.00K 10-Q · filed 2025-08-07 | $6.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $18.00K 10-Q · filed 2025-05-08 | $6.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$19.00K derived: sum of 2 quarters · filed 2026-02-26 | -$17.00K derived: sum of 3 quarters · filed 2026-02-26 | -$56.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.00K derived: sum of 2 quarters · filed 2024-11-12 | -$44.00K 10-Q · filed 2024-11-12 | -$69.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$37.00K 10-Q · filed 2024-08-09 | -$62.00K derived: sum of 3 quarters · filed 2025-03-03 | $13.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$39.00K 10-Q · filed 2024-05-10 | -$64.00K derived: sum of 2 quarters · filed 2025-03-03 | $11.00K derived: sum of 3 quarters · filed 2025-03-03 | $11.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $50.00K derived: sum of 2 quarters · filed 2025-03-03 | $50.00K derived: sum of 3 quarters · filed 2025-03-03 | $50.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $75.00K derived: sum of 2 quarters · filed 2023-11-09 | $75.00K 10-Q · filed 2023-11-09 | $75.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |